Trials / Not Yet Recruiting
Not Yet RecruitingNCT06427044
Effect of Bupivacaine Liposome Anterior Serratus Deep Block on Chronic Pain After Breast Cancer Surgery: a Randomized Controlled Study
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 143 (estimated)
- Sponsor
- Lu Hua · Academic / Other
- Sex
- Male
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate the effect and influence of liposome bupivacaine anterior serrat plane block on postoperative chronic pain in breast cancer patients, evaluate the therapeutic effect of liposome bupivacaine in postoperative chronic pain, and provide a new method for patients with postoperative chronic pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anterior serratus block group | Bupivacaine lipid 20mL (20mL 266mg bupivacaine liposomes) was ultrasound-guided for a single anterior serranus plane block |
Timeline
- Start date
- 2024-05-25
- Primary completion
- 2024-12-30
- Completion
- 2024-12-30
- First posted
- 2024-05-23
- Last updated
- 2024-05-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06427044. Inclusion in this directory is not an endorsement.